A 48-year-old woman with type 2 diabetes and hypertension is found to have a lipid panel: total cholesterol 220 mg/dL, LDL-C 140 mg/dL, HDL-C 32 mg/dL, triglycerides 380 mg/dL. Which feature best distinguishes Type III hyperlipoproteinaemia (dysbetalipoproteinaemia) from Type IV hyperlipoproteinaemia?

Explanation

## Type III vs Type IV Hyperlipoproteinaemia ### Pathophysiological Basis **Key Point:** Type III (dysbetalipoproteinaemia) results from **impaired remnant clearance** (apoE2/E2 genotype + secondary trigger), causing **accumulation of cholesterol-rich IDL/remnants**. Type IV involves **increased VLDL secretion** with normal or mildly impaired clearance, causing **elevated triglycerides with relatively lower cholesterol**. ### Comparison Table | Feature | Type III (Dysbetalipoproteinaemia) | Type IV (VLDL Overproduction) | |---------|-------------------------------------|-------------------------------| | **Primary defect** | Impaired remnant clearance (apoE2/E2) | Increased hepatic VLDL secretion | | **Lipoprotein pattern** | Accumulation of β-VLDL (IDL-like) | Elevated VLDL, normal LDL | | **Cholesterol level** | Elevated (often >250 mg/dL) | Moderate (200–250 mg/dL) | | **Triglycerides** | Elevated (200–500 mg/dL) | Elevated (200–500 mg/dL) | | **Chol:TG ratio** | **>0.2** (cholesterol-rich) | **<0.2** (TG-rich) | | **LDL-C** | Normal or low | Normal or slightly elevated | | **Apolipoprotein B** | Elevated (multiple remnant particles) | Elevated (multiple VLDL particles) | | **Xanthomas** | Tuberoeruptive (palms, elbows, knees) | Eruptive (extensor surfaces) | | **Genetic basis** | ApoE2/E2 (homozygous) | Polygenic; insulin resistance | | **Age of onset** | Typically 20–40 years | Typically 30–50 years | ### Why Option 2 is Correct **High-Yield:** Type III dysbetalipoproteinaemia is **uniquely characterized** by: 1. **Accumulation of β-VLDL** — cholesterol-rich remnant particles that migrate in the LDL fraction on electrophoresis but are actually IDL/remnants 2. **Cholesterol-to-triglyceride ratio >0.2** — this is the **single best laboratory discriminator** because the accumulated particles are cholesterol-rich 3. **Both cholesterol and triglycerides are elevated** (often in a 1:1 to 1:2 ratio) Type IV, by contrast, shows a **TG-rich VLDL pattern** with a **Chol:TG ratio <0.2**, reflecting the predominance of triglyceride-laden VLDL particles. ### Clinical Pearl **Clinical Pearl:** Type III is sometimes called "**broad-beta disease**" because β-VLDL (remnants) migrate in the LDL region on lipoprotein electrophoresis, creating a broad band. This is a pathognomonic finding. Type IV shows a normal LDL band with elevated VLDL. ### Mnemonic **Mnemonic: "Type III = Remnant Remnant" (cholesterol-rich); "Type IV = VLDL Very Triglyceride-rich"** - Type III: **Chol > TG** (ratio >0.2) → remnant accumulation - Type IV: **TG > Chol** (ratio <0.2) → VLDL overproduction ### Diagnostic Approach ```mermaid flowchart TD A[Elevated cholesterol + TG]:::outcome --> B{Chol:TG ratio?}:::decision B -->|>0.2| C[Cholesterol-rich particles]:::action C --> D[Type III: β-VLDL accumulation]:::outcome B -->|<0.2| E[Triglyceride-rich particles]:::action E --> F[Type IV: VLDL overproduction]:::outcome D --> G[Check apoE genotype]:::action G --> H[E2/E2 + secondary trigger?]:::decision H -->|Yes| I[Confirm Type III]:::outcome F --> J[Check family history + insulin resistance]:::action ``` ### Secondary Triggers for Type III **High-Yield:** Type III requires **both** apoE2/E2 genotype **AND** a secondary trigger: - Obesity - Diabetes mellitus - Hypothyroidism - Renal disease - Alcohol excess Without the trigger, E2/E2 individuals remain asymptomatic.